Teicoplanin Injection I.P. 400MG

Teicoplanin Injection I.P. 400 mg
Precision Power Against Gram-Positive Infections

Teicoplanin 400 mg Injection is a high-efficacy glycopeptide antibiotic designed for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). With once-daily dosing and a favorable safety profile, it is an ideal choice for inpatient and outpatient parenteral therapy.

Potent Gram-Positive Coverage – Effective against MRSA, Enterococcus faecalis, Streptococcus pneumoniae, and coagulase-negative staphylococci
Flexible Administration – Can be administered intravenously or intramuscularly, offering versatility in clinical settings
Long Half-Life – Supports once-daily dosing, improving convenience and compliance
Renowned Safety Profile – Well-tolerated with a low risk of nephrotoxicity compared to other glycopeptides

Indications:
Treatment of serious infections such as bacteremia, endocarditis, skin and soft tissue infections, bone and joint infections, and lower respiratory tract infections caused by gram-positive organisms.

Important Safety Information:
Monitor renal function and blood counts during prolonged therapy. Use with caution in patients with known hypersensitivity to glycopeptides.